At 9.6% CAGR, the Asia Pacific Biosafety Cabinet Market is projected to be worth US$ 57.42 million by 2028, says The Business Market Insights    

According to the Business Market Insights’ research, the Asia Pacific biosafety cabinet market was valued at US$ 36.23 million in 2023 and is expected to reach US$ 57.42 million by 2028, registering a CAGR of 9.6% from 2023 to 2028.  Rising prevalence of infectious diseases and rising strategic initiatives are the critical factors attributed to the Asia Pacific biosafety cabinet market expansion. 

R&D is a significant and essential part of the business of pharmaceuticals and biopharmaceutical companies. R&D enables companies to come up with new medicines for various therapeutic applications with significant medical and commercial potential. There has been an increase in R&D spending by biopharmaceutical companies over the years.  Drug development and discovery are time-consuming and expensive processes. These processes involves various stages, including early detection of a target, designing of a molecule, and development and regulatory approval. The entire process can take more than 10–15 years. Throughout the drug development phase, various testing services are required to check the quality and efficacy of the drug. In the development and modification of a new vaccine strain for infectious disease, various cell culture studies and experiments are performed that majorly requires biosafety cabinets.  Furthermore, increasing demand for smart laboratories has led to the development of smart biosafety cabinets with cloud-based, Internet of Things (IoT), and Artificial Intelligence (AI) technologies. Thus, the rising number of molecules entering clinical trial studies and ramp-up in R&D, along with the growing trend of smart laboratories, will create ample opportunities for the Asia Pacific biosafety cabinet market during the forecast period. 

On the contrary, high cost and maintenance of biosafety cabinets hurdles the growth of Asia Pacific biosafety cabinet market.

Based on products handled, the Asia Pacific biosafety cabinet market is bifurcated into biological products and toxic products. The biological products segment held 90.5% share of Asia Pacific biosafety cabinet market in 2023, amassing US$ 32.80 million. It is projected to garner US$ 51.30 million by 2028 to expand at 9.4% CAGR during 2023–2028.      

Based on category, the Asia Pacific biosafety cabinet market is segmented into work trays, side panel construction, and accessories. The work trays segment held 61.1% share of Asia Pacific biosafety cabinet market in 2023, amassing US$ 22.12 million. It is projected to garner US$ 35.41 million by 2028 to expand at 9.9% CAGR during 2023–2028.           

Based on type, the Asia Pacific biosafety cabinet market is segmented into class I biosafety cabinet, class II type A2 & class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. The class II type A2 & class II type B1 segment held 80.3% share of Asia Pacific biosafety cabinet market in 2023, amassing US$ 29.10 million. It is projected to garner US$ 47.02 million by 2028 to expand at 10.1% CAGR during 2023–2028.         

Based on application, the Asia Pacific biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. The disease prevention segment held 52.2% share of Asia Pacific biosafety cabinet market in 2023, amassing US$ 18.93 million. It is projected to garner US$ 30.20 million by 2028 to expand at 9.8% CAGR during 2023–2028.            

Based on end user, the Asia Pacific biosafety cabinet market is segmented into academic centers, biotech & pharmaceutical companies, microbiology centers, research & development centers, hospitals & clinics, diagnostic laboratories, and others. The biotech & pharmaceutical companies segment held 49.0% share of Asia Pacific biosafety cabinet market in 2023, amassing US$ 17.76 million. It is projected to garner US$ 28.85 million by 2028 to expand at 10.2% CAGR during 2023–2028.              

Based on country, the Asia Pacific biosafety cabinet market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.2% market share in 2023. It was assessed at US$ 10.58 million in 2023 and is likely to hit US$ 16.62 million by 2028, exhibiting a CAGR of 9.5% during the forecast period.             

Key players dominating the Asia Pacific biosafety cabinet market are ACMAS Technologies, Biobase Biodusty Co Ltd, Esco Group of Companies, Haier Biomedical, Heal Force Bio-Meditech Holdings Ltd, International Marketers for Scientific Equipment’s & Technologies (IMSET), Kewaunee Scientific Corp, Labconco Corp, NuAire Inc, and Thermo Fisher Scientific Inc among others. 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com